Business Associates Login To Trade Open An Account Activate An Account
Super Trader Home FAQ Careers Sitemap Contact Us  
 
EQUITY  |  DERIVATIVES  |  IPO  |  MUTUAL FUND  |  STOCK FUNDAMENTALS  |  STOCK CHART  |  STOCK FILTER
 
   Select Company |  Company Profile |  Quotes |  Company History |  Share Holding Pattern |  Board of Directors |  Key Executives   
   Product Report |  Raw Material Report |  Bankers/Auditors/Registrar |  High-Lows |  Capital Structure |  Locations |  Results |  News   
   Director's Reports |  Auditor Reports |  Notes To Account |  Accounting Policies |  Chairman's Speech |  Close Prices |  MF's Holding this Scrip   
Home > Equity Market > Dr. Reddy's Laboratories Ltd. -News >

Dr. Reddy's Laboratories Ltd. - News

Industry: Pharmaceuticals
BSE Code :500124
NSE Code :DRREDDY
Business Group:Reddy Group
LTP (Rs.) :2966.25  (0.0%) [NSE]
ISIN No :INE089A01023
Face Value/M Lot :5.00/1
P/E Ratio : 26.15
Market Cap : 50534.77 Cr
You can view the entire list of various company related news
Headlines Date
Dr. Reddy's Labs - Shareholding Pattern For September 30, 2014 18/10/2014
Dr. Reddy's Laboratories Ltd. - News Clarification 09/10/2014
Dr. Reddy's Labs - Q2 results on Oct 29, 2014 06/10/2014
Dr Reddy’s launches Levalbuterol Inhalation Solution 24/09/2014
Dr. Reddy's Labs - Dr. Reddy's announces the Launch of LEVALBUTEROL INHALATION SOLUTION, USP FOR ORAL INHALATION ONLY 24/09/2014
Dr. Reddy's Labs - Allotment of Equity Shares on exercise of ESOP 04/09/2014
Dr. Reddys Labs - Disclosure of Voting results of AGM (Clause 35A) 01/08/2014
Dr Reddy’s Lab Q1 Cons net up 52% at Rs 550.39 cr 30/07/2014
Dr. Reddys Labs - Announces Q1 Results, Results Press Release & Limited Review Report for June 30, 2014 30/07/2014
Dr. Reddys Labs - Shareholding Pattern For June 30, 2014 18/07/2014
Dr. Reddys Labs - Grant of Stock Options 15/07/2014
Dr Reddys Laboratories to declare Q1 financial results on July 30 08/07/2014
Dr. Reddys Labs - Q1 results on July 30, 2014 07/07/2014
Dr. Reddy's launches Duloxetine delayed-release capsules in US 27/06/2014
Dr. Reddys Labs - Dr. Reddy's announces the Launch of Duloxetine Delayed-Release Capsules USP 27/06/2014
Dr. Reddys Labs - Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F 27/06/2014
Dr Reddy's launches Paricalcitol capsules 25/06/2014
Dr. Reddys Labs - Dr. Reddy's announces the Launch of Paricalcitol Capsules 25/06/2014
Dr. Reddys Labs - Allotment of Equity Shares on exercise of ESOP 24/06/2014
Dr. Reddys Labs - Clarification with regard to E-Voting Facility to the Shareholders 23/06/2014
Dr Reddy’s initiates voluntary recall of drug from US market 19/06/2014
Dr Reddys grants option various schemes 16/06/2014
Dr. Reddys Labs - Grant of Stock Options 16/06/2014
Dr Reddy’s introduces Melgain lotion for vitiligo treatment 13/06/2014
Dr. Reddys Labs - Fixes Book Closure for Dividend & AGM 03/06/2014
Dr. Reddys Labs - Allotment of Equity Shares on exercise of ESOP 03/06/2014
Dr Reddys grants options under ESOS 2002 26/05/2014
Dr. Reddys Labs - Grant of Stock Options 26/05/2014
Dr Reddys’ consolidated Q4 net dips 15.6% at Rs 481.60 cr 13/05/2014
Dr Reddy’s appoints Satish Reddy as Chairman 13/05/2014

Get the latest share market news and updates from NSE and BSE with Kotak Securities. Catch up on the latest stories, information on Dr. Reddy's Laboratories Ltd. share prices, and industry specific announcements for more information visit the Dr. Reddy's Laboratories Ltd. profile page. Stay ahead of the curve by spotting market trends, stock movements and make well informed investment decisions on time every time.

Enter first few characters
  
  ETFs (Exchange Traded Funds)